Bilirubin in Urine: What It Means and When It's a Warning Sign

Published

Last updated

Key takeaway:

Bilirubin is not normally present in urine; its appearance (bilirubinuria) indicates conjugated bilirubin has spilled into the bloodstream due to liver disease, bile duct obstruction, or drug-induced injury. This finding is inherently abnormal and warrants follow-up blood testing (liver function panel including direct bilirubin, ALT, AST, ALP) and imaging when obstruction is suspected.

Read more →

Understand what your liver function testing results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Quick answer: Bilirubin is not normally present in urine. Its appearance (bilirubinuria) indicates that conjugated (direct) bilirubin is being excreted by the kidneys, which happens when liver disease or bile duct obstruction allows conjugated bilirubin to accumulate in the bloodstream. A positive urine bilirubin finding warrants follow-up blood testing to identify the underlying cause.

Urine dipstick result: what it means

Only a negative result is normal. A 1+ result, or even a trace, is abnormal.

Dipstick resultWhat it meansNext step
NegativeNormal: no bilirubin detectedNone
TraceAbnormal: conjugated bilirubin is elevated in the blood, and even a trace can be clinically significantConfirm with a formal urinalysis, then liver function blood tests
Small (1+)Abnormal: conjugated bilirubin is elevated in the bloodConfirm with a formal urinalysis, then liver function blood tests
Moderate (2+)Abnormal: conjugated bilirubin is elevated in the bloodConfirm with a formal urinalysis, then liver function blood tests
Large (3+)Abnormal: conjugated bilirubin is elevated in the bloodConfirm with a formal urinalysis, then liver function blood tests

What is bilirubin and where does it come from?

Bilirubin is a yellow breakdown product of heme, the iron-containing component of hemoglobin. When red blood cells reach the end of their roughly 120-day lifespan, they are destroyed in the spleen and liver, releasing hemoglobin. The heme portion is converted to biliverdin and then to bilirubin in the process of normal red cell turnover.

Bilirubin travels in two clinically important forms. Unconjugated (indirect) bilirubin is fat-soluble, cannot be filtered by the kidneys, and is therefore not present in urine under normal circumstances. The liver conjugates (chemically modifies) bilirubin to make it water-soluble; this conjugated (direct) bilirubin is then secreted into bile and passes into the intestine for excretion in stool. Under healthy conditions, minimal conjugated bilirubin enters the systemic circulation, and essentially none appears in urine.

When bilirubin is detected in urine, it is conjugated bilirubin that has spilled into the bloodstream (rather than being excreted into bile) and is being filtered by the kidneys. This is inherently abnormal and points to a disruption somewhere in the hepatic or biliary system.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

What causes bilirubin in urine?

Liver disease

Any condition that impairs the liver's ability to excrete conjugated bilirubin into bile will allow it to accumulate in the bloodstream and spill into urine. Hepatitis (viral, autoimmune, or toxic), alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD) with significant fibrosis, and cirrhosis are among the most common causes. In acute viral hepatitis, bilirubinuria often appears before jaundice becomes visible and may persist during the recovery phase. The urine characteristically takes on a dark, tea-colored appearance when bilirubin levels are significantly elevated.

Relevant blood markers: total bilirubin, direct bilirubin, ALT, AST, alkaline phosphatase (ALP), and albumin. Collectively, these constitute the standard liver function panel. Reference ranges vary by laboratory and individual; results require clinical interpretation.

Bile duct obstruction (cholestasis)

Obstruction of the bile duct prevents conjugated bilirubin from reaching the intestine. It accumulates in the liver, enters the bloodstream, and is excreted by the kidneys, producing bilirubinuria. Common causes of bile duct obstruction include gallstones lodged in the common bile duct (choledocholithiasis), strictures (narrowings) from scarring or inflammation, and, in more serious presentations, cholangiocarcinoma (bile duct cancer) or pancreatic head tumors compressing the bile duct.

Cholestatic obstruction typically produces a distinctive pattern on liver function testing: disproportionate elevation of ALP and gamma-glutamyl transferase (GGT) relative to ALT and AST. This pattern directs the clinical evaluation toward biliary rather than hepatocellular disease. Imaging (usually ultrasound first) is essential to identify structural causes.

Hemolytic conditions and increased red cell breakdown

In hemolytic conditions, accelerated red cell destruction produces large amounts of unconjugated bilirubin that overwhelms the liver's conjugating capacity. The liver responds by conjugating as much as possible, some of which reaches the circulation. However, bilirubinuria is less characteristic of pure hemolysis than of hepatic or cholestatic disease; unconjugated bilirubin dominates in hemolysis and does not appear in urine. If bilirubinuria is present in a hemolytic context, concurrent hepatic involvement should be considered.

Markers for hemolysis include hemoglobin, hematocrit, lactate dehydrogenase (LDH), and haptoglobin, along with a peripheral blood smear reviewed by a clinician.

Drug-induced liver injury (DILI)

Numerous medications and supplements can cause hepatocellular or cholestatic injury that produces bilirubinuria. Acetaminophen overdose is the most common cause of acute liver failure in many countries. Antibiotics (particularly amoxicillin-clavulanate and fluoroquinolones), antifungals, statins, and certain herbal supplements are also recognized causes. If bilirubinuria occurs in temporal association with starting a new medication, drug-induced liver injury should be considered and the prescribing provider notified.

What bilirubin in urine does not mean

A positive urine dipstick for bilirubin should be confirmed with a formal urinalysis and correlated with blood bilirubin levels. False positives can occur with certain medications (phenothiazines, rifampin) and when urine has been exposed to light for an extended period (bilirubin degrades rapidly). A single positive dipstick finding is not a diagnosis; it is a signal that warrants further evaluation.

Urobilinogen vs bilirubin in urine

Urobilinogen and bilirubin are separate results on a urine dipstick, and they mean different things. Urobilinogen forms in the intestine, where gut bacteria reduce bilirubin to urobilinogen. Small amounts of urobilinogen in urine are normal. Bilirubin should be absent in healthy urine, and any amount points to conjugated bilirubin spilling over from the blood.

Test 100+ biomarkers

One blood draw. A full picture of your health, explained in plain language.

Book your test

Which blood tests to order after finding bilirubin in urine

  • Total + direct bilirubin — Confirms elevation; ratio of direct to total indicates hepatic vs. hemolytic pattern — total bilirubin
  • ALT — Hepatocellular injury marker; elevated in hepatitis and liver cell damage — ALT
  • AST — Hepatocellular and cardiac marker; pattern with ALT guides diagnosis — AST
  • Alkaline phosphatase — elevated in cholestasis; disproportionate rise suggests bile duct problem — alkaline phosphatase
  • Albumin — liver synthetic function; low albumin suggests chronic or severe liver disease — albumin
  • Total protein — reflects liver production capacity alongside albumin — total protein

Superpower's Baseline Blood Panel includes total bilirubin, ALT, AST, alkaline phosphatase, albumin, and total protein as part of a comprehensive metabolic assessment. These markers collectively provide the pattern needed to characterize the likely mechanism behind bilirubinuria.

When does bilirubin in urine require urgent evaluation?

Bilirubinuria is rarely an emergency in isolation, but certain accompanying findings should prompt clinical evaluation rather than watchful waiting:

  • Visible jaundice (yellow skin or whites of the eyes)
  • Dark urine with pale or clay-colored stools (a classic cholestasis pattern)
  • Significant right upper quadrant abdominal pain or tenderness
  • Fever with jaundice (may indicate cholangitis, which requires urgent treatment)
  • Known liver disease with new-onset bilirubinuria indicating decompensation

If bilirubinuria is identified incidentally on a routine urinalysis without symptoms, follow-up blood testing and clinical assessment remain appropriate but are generally not urgent. Your provider will determine the appropriate timeline based on the complete clinical picture.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health routine. Superpower offers blood panels that include the biomarkers discussed in this article. Links to individual tests are provided for informational context.

Frequently Asked Questions

References

  1. Corrons JLV, Casafont LB, Frasnedo EF (2021). Concise review: how do red blood cells born, live, and die?. *Annals of hematology*, *100*(10), 2425-2433. https://doi.org/10.1007/s00277-021-04575-z
  2. Kalakonda A, Jenkins BA, John S (2022). *Physiology, bilirubin*. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470290/
  3. Kupka T, Binder LS, Smith DA, Nelson BK, Wainscott MP, Glass BA (1987). Accuracy of urine urobilinogen and bilirubin assays in predicting liver function test abnormalities. *Annals of emergency medicine*, *16*(11), 1231-5. https://doi.org/10.1016/s0196-0644(87)80229-9
  4. Hoilat GJ, John S (2023). *Bilirubinuria*. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557439/
  5. Guerra Ruiz AR, Crespo J, López Martínez RM, Iruzubieta P, Casals Mercadal G, Lalana Garcés M, Lavin B, Morales Ruiz M (2021). Measurement and clinical usefulness of bilirubin in liver disease. *Advances in laboratory medicine*, *2*(3), 352-372. https://doi.org/10.1515/almed-2021-0047
  6. Lee WM (2008). Acetaminophen-related acute liver failure in the United States. *Hepatology research : the official journal of the Japan Society of Hepatology*, *38 Suppl 1*, S3-8. https://doi.org/10.1111/j.1872-034X.2008.00419.x
  7. Vítek L, Tiribelli C (2025). Gut microbiota and bilirubin metabolism: unveiling new pathways in health and disease. *Trends in molecular medicine*, *31*(7), 591-594. https://doi.org/10.1016/j.molmed.2024.12.007
  8. Koff RS (1992). Clinical manifestations and diagnosis of hepatitis A virus infection. *Vaccine*, *10 Suppl 1*, S15-7. https://doi.org/10.1016/0264-410x(92)90533-p

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize100+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions from a single blood draw - then act on what you find.

$199

/year*

100+ biomarkers from a single blood draw

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.55 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 100+ biomarkers from a single blood draw each year. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.